Literature DB >> 25917388

CD8 T cells and Mycobacterium tuberculosis infection.

Philana Ling Lin1, JoAnne L Flynn.   

Abstract

Tuberculosis is primarily a respiratory disease that is caused by Mycobacterium tuberculosis. M. tuberculosis can persist and replicate in macrophages in vivo, usually in organized cellular structures called granulomas. There is substantial evidence for the importance of CD4 T cells in control of tuberculosis, but the evidence for a requirement for CD8 T cells in this infection has not been proven in humans. However, animal model data support a non-redundant role for CD8 T cells in control of M. tuberculosis infection. In humans, infection with this pathogen leads to generation of specific CD8 T cell responses. These responses include classical (MHC Class I restricted) and non-classical CD8 T cells. Here, we discuss the potential roles of CD8 T cells in defense against tuberculosis, and our current understanding of the wide range of CD8 T cell types seen in M. tuberculosis infection.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25917388      PMCID: PMC4439333          DOI: 10.1007/s00281-015-0490-8

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  81 in total

1.  CD1-restricted microbial lipid antigen-specific recognition found in the CD8+ alpha beta T cell pool.

Authors:  J P Rosat; E P Grant; E M Beckman; C C Dascher; P A Sieling; D Frederique; R L Modlin; S A Porcelli; S T Furlong; M B Brenner
Journal:  J Immunol       Date:  1999-01-01       Impact factor: 5.422

Review 2.  Multifunctional immune responses of HMBPP-specific Vγ2Vδ2 T cells in M. tuberculosis and other infections.

Authors:  Zheng W Chen
Journal:  Cell Mol Immunol       Date:  2012-11-12       Impact factor: 11.530

3.  Effect of dose and route of immunisation on the immune response induced in cattle by heterologous Bacille Calmette-Guerin priming and recombinant adenoviral vector boosting.

Authors:  G Dean; D Clifford; S Gilbert; H McShane; R G Hewinson; H M Vordermeier; B Villarreal-Ramos
Journal:  Vet Immunol Immunopathol       Date:  2014-01-28       Impact factor: 2.046

4.  Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis.

Authors:  S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

5.  Human mucosal associated invariant T cells detect bacterially infected cells.

Authors:  Marielle C Gold; Stefania Cerri; Susan Smyk-Pearson; Meghan E Cansler; Todd M Vogt; Jacob Delepine; Ervina Winata; Gwendolyn M Swarbrick; Wei-Jen Chua; Yik Y L Yu; Olivier Lantz; Matthew S Cook; Megan D Null; David B Jacoby; Melanie J Harriff; Deborah A Lewinsohn; Ted H Hansen; David M Lewinsohn
Journal:  PLoS Biol       Date:  2010-06-29       Impact factor: 8.029

6.  Immunization with a mycobacterial lipid vaccine improves pulmonary pathology in the guinea pig model of tuberculosis.

Authors:  Christopher C Dascher; Kenji Hiromatsu; Xiaowei Xiong; Caroline Morehouse; Gerald Watts; Gui Liu; David N McMurray; Kenneth P LeClair; Steven A Porcelli; Michael B Brenner
Journal:  Int Immunol       Date:  2003-08       Impact factor: 4.823

7.  CD39 is involved in mediating suppression by Mycobacterium bovis BCG-activated human CD8(+) CD39(+) regulatory T cells.

Authors:  Mardi C Boer; Krista E van Meijgaarden; Jérémy Bastid; Tom H M Ottenhoff; Simone A Joosten
Journal:  Eur J Immunol       Date:  2013-05-29       Impact factor: 5.532

8.  Correction of the iron overload defect in beta-2-microglobulin knockout mice by lactoferrin abolishes their increased susceptibility to tuberculosis.

Authors:  Ulrich E Schaible; Helen L Collins; Friedrich Priem; Stefan H E Kaufmann
Journal:  J Exp Med       Date:  2002-12-02       Impact factor: 14.307

9.  Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis.

Authors:  S M Behar; C C Dascher; M J Grusby; C R Wang; M B Brenner
Journal:  J Exp Med       Date:  1999-06-21       Impact factor: 14.307

10.  A critical role for CD8 T cells in a nonhuman primate model of tuberculosis.

Authors:  Crystal Y Chen; Dan Huang; Richard C Wang; Ling Shen; Gucheng Zeng; Shuyun Yao; Yun Shen; Lisa Halliday; Jeff Fortman; Milton McAllister; Jim Estep; Robert Hunt; Daphne Vasconcelos; George Du; Steven A Porcelli; Michelle H Larsen; William R Jacobs; Barton F Haynes; Norman L Letvin; Zheng W Chen
Journal:  PLoS Pathog       Date:  2009-04-17       Impact factor: 6.823

View more
  77 in total

1.  Specific T cell induction using iron oxide based nanoparticles as subunit vaccine adjuvant.

Authors:  Lázaro Moreira Marques Neto; Nicholas Zufelato; Ailton Antônio de Sousa-Júnior; Monalisa Martins Trentini; Adeliane Castro da Costa; Andris Figueiroa Bakuzis; André Kipnis; Ana Paula Junqueira-Kipnis
Journal:  Hum Vaccin Immunother       Date:  2018-07-12       Impact factor: 3.452

2.  Impaired Cytokine but Enhanced Cytotoxic Marker Expression in Mycobacterium tuberculosis-Induced CD8+ T Cells in Individuals With Type 2 Diabetes and Latent Mycobacterium tuberculosis Infection.

Authors:  Nathella Pavan Kumar; Kadar Moideen; Parakkal Jovvian George; Chandrakumar Dolla; Paul Kumaran; Subash Babu
Journal:  J Infect Dis       Date:  2015-10-20       Impact factor: 5.226

Review 3.  Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.

Authors:  Joshua S Davis; David Ferreira; Emma Paige; Craig Gedye; Michael Boyle
Journal:  Clin Microbiol Rev       Date:  2020-06-10       Impact factor: 26.132

Review 4.  Regulation of the Cell Biology of Antigen Cross-Presentation.

Authors:  J Magarian Blander
Journal:  Annu Rev Immunol       Date:  2018-02-28       Impact factor: 28.527

Review 5.  Long non-coding RNAs in immune regulation and their potential as therapeutic targets.

Authors:  Dinesh Babu Uthaya Kumar; Adam Williams
Journal:  Int Immunopharmacol       Date:  2020-02-12       Impact factor: 4.932

6.  Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria.

Authors:  Samuel J Balin; Matteo Pellegrini; Eynav Klechevsky; Sohui T Won; David I Weiss; Aaron W Choi; Joshua Hakimian; Jing Lu; Maria Teresa Ochoa; Barry R Bloom; Lewis L Lanier; Steffen Stenger; Robert L Modlin
Journal:  Sci Immunol       Date:  2018-08-31

7.  Distinct Host-Mycobacterial Pathogen Interactions between Resistant Adult and Tolerant Tadpole Life Stages of Xenopus laevis.

Authors:  Kun Hyoe Rhoo; Eva-Stina Edholm; María J Forzán; Adil Khan; Anthony W Waddle; Martin S Pavelka; Jacques Robert
Journal:  J Immunol       Date:  2019-10-07       Impact factor: 5.422

Review 8.  Influence of diabetes mellitus on immunity to human tuberculosis.

Authors:  Pavan Kumar Nathella; Subash Babu
Journal:  Immunology       Date:  2017-06-29       Impact factor: 7.397

Review 9.  Moving tuberculosis vaccines from theory to practice.

Authors:  Peter Andersen; Thomas J Scriba
Journal:  Nat Rev Immunol       Date:  2019-09       Impact factor: 53.106

Review 10.  The knowns and unknowns of latent Mycobacterium tuberculosis infection.

Authors:  W Henry Boom; Ulrich E Schaible; Jacqueline M Achkar
Journal:  J Clin Invest       Date:  2021-02-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.